Vaccinex, Inc - VCNX Net earnings per share for the last four quarters

Official company branding of Vaccinex, Inc (VCNX)

Vaccinex, Inc. is scaling its research through clinic partnerships, while relying on a minimal staff of loyal scientists and external contractors. The EPS YoY TTM trend reflects current financial patterns, with the indicator reaching 20.70. Vaccinex, Inc. is implementing advanced antibodies to combat oncology and multiple sclerosis by blocking proteins that hinder tissue regeneration.

Vaccinex (VCNX) Earnings per share for the last twelve months: for the period 02/11/2024 - 02/20/2024

VCNX (Vaccinex): analytical breakdowns and indicator data

Initial company analysis:VCNX, Vaccinex, Inc
Mass-produced product of vaccinex.com

Vaccinex, Inc. operates as a flexible biotech hub, outsourcing its manufacturing processes to third-party contractors. Analyzing this annual EPS TTM chart, an investor can see the actual growth in earnings per share over a rolling year. This metric neutralizes short-term volatility, capturing the actual financial result. The high amplitude of fluctuations on the chart reflects the risks associated with the outsourcing model. This indicator determines the fundamental stability of the business in the absence of capital expenditures.

Direct competitors

Earnings per share for the trailing year IBRX (ImmunityBio)|IMCR: Net earnings per share (EPS TTM)|JANX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months arcusbio.com|Net earnings per share for the last 12 months zymeworks.com (ZYME)|Earnings per share for the last twelve months Tango Therapeutics Inc (TNGX)|Net earnings per share for the last 12 months Iovance IOVA|Immatics NV - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Xencor Inc. XNCR|CMPX - Earnings per share for the last twelve months|REPL (replimune.com) - Earnings per share for the last 12 months|Lyell Pharma (LYEL) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Innate Pharma, S.A. (IPHA)|Net earnings per share for the last 12 months PYXS|CGEN - Net earnings per share for the trailing year|Net earnings per share for the last 12 months IOBT (IO Biotech Corp)|Earnings per share for the last four quarters STRO|Net earnings per share (EPS TTM) INKT (MiNK Therapeutics)|Earnings per share for the trailing year HOWL|Immix - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ALX Oncology Holdings Inc.|CUE: Net earnings per share (EPS TTM)|PDS Biotech - Earnings per share for the trailing year|SONN (Sonnet BioTherapeutics Holdings Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) MAIA Biotech|Earnings per share for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Earnings per one share for the last 12 months|NextCure Inc - Net earnings per share for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Net earnings per one share for the last twelve months|Intensity Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters senseibio.com SNSE|TOVX: Net earnings per share (EPS TTM)|Gritstone bio Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months KA|Earnings per share for the last 12 months NEXI (NexImmune, Inc.)|Earnings per share for the last twelve months Turnstone Biologics Corporation (TSBX)|HARP: Earnings per one share for the last 12 months